5-Amino-1MQ: What the Research Shows and What It Doesn't

5-Amino-1MQ is an experimental small molecule that blocks an enzyme called NNMT. In obese mice it has reduced body weight and fat mass. In people, its benefits, safety and dose are unknown. It is not an FDA-approved drug, and despite how it is marketed, it is not a peptide. This guide explains what the science says, why online claims run ahead of it, and what to ask a clinician if you are curious about metabolic support.

TL;DR

5-Amino-1MQ is a small-molecule NNMT inhibitor, not a peptide. The best-known data come from a mouse study of diet-induced obesity.
We found no registered human trials on ClinicalTrials.gov for this compound, so no human dose, benefit or safety profile has been established.
Capsules and vials sold online as "research compounds" are not the same as FDA-approved medicines, and a listed purity figure does not prove safety or effectiveness.
If weight or energy is the real concern, a clinician can check labs, review your medications and discuss options that have human evidence.

What 5-Amino-1MQ is
How it is supposed to work
What the mouse data show
Human evidence: where things stand
Approved, compounded and investigational: three different things
Reading an online product page
Possible risks to take seriously
What has human evidence for weight management
Our perspective
How to prepare for a clinician conversation
Talking to a clinician through AirMedFit
FAQ
Sources

What 5-Amino-1MQ is

The full name is 5-amino-1-methylquinolinium. It is a small, cell-permeable molecule designed to inhibit nicotinamide N-methyltransferase (NNMT). The original chemistry work, published by Neelakantan and colleagues, described a series of NNMT inhibitors and tested them in cells and in mice.

Many retail pages call it a "peptide" because it is sold alongside peptides. That label is wrong. Peptides are short chains of amino acids. This compound is a quinolinium salt, a different chemical class. The distinction matters because the rules, manufacturing standards and evidence for each product class differ, and a reader who assumes it belongs to a known peptide family may assume things that are untrue.

How it is supposed to work

NNMT is an enzyme found in fat tissue and the liver. The working hypothesis is that blocking it could raise levels of NAD+ and S-adenosylmethionine (SAM) inside cells, which in turn might shift how fat cells handle energy. The study authors proposed NNMT as a potential target for obesity and type 2 diabetes, according to the published paper.

This is a hypothesis built from cell and rodent work. It has not been confirmed as a treatment mechanism in people. If you want background on the NAD+ side of the story, our piece on NAD+ injection benefits and when to see a physician covers what blood-level data do and do not tell you.

What the mouse data show

In the diet-induced obesity experiments, treated mice lost about 5.1% of body weight over 11 days, while control mice gained about 1.4%. Treated animals also had roughly 35% less epididymal white adipose tissue and about 30% lower total plasma cholesterol.

Those numbers are real, and they are why the compound attracts attention. But read them with three limits in mind:

Species. Mice are not small people. Many compounds that melt fat in rodents do nothing useful, or cause harm, in humans.
Duration. Eleven days says little about long-term effects, tolerance or safety.
Scope. The evidence base is a small group of studies from a limited number of labs. We are not aware of independent human replication or human pharmacokinetic data, meaning nobody has shown how the body absorbs, processes and clears it at a given dose.

That last point is why any dosing schedule you find online is a guess. A schedule is only evidence-based when trials have measured what a dose does in people.

Human evidence: where things stand

As of October 18, 2026, our check of ClinicalTrials.gov found no registered human studies of 5-Amino-1MQ, whether completed, recruiting or otherwise. Registries change, so you can repeat the search yourself by typing the compound name into the site.

What that means in plain terms:

No published human randomized controlled trial supports weight loss, fat loss, energy or anti-aging claims.
No human data define a safe dose, side effects or interactions with other medicines.
Claims that it "stacks" with GLP-1 medicines or NAD+ are extrapolations, not findings. Nobody has tested those combinations in people that we can find.

People also ask how long it takes to work, how often to take it, and whether it can go with NAD+. The honest answers are the same for all three: there are no human data to say. We will not give a schedule, because a schedule would imply knowledge that does not exist.

Approved, compounded and investigational: three different things

Product pages blur these categories on purpose. Keep them apart.

Category	What it means	Example in weight care
FDA-approved	The FDA reviewed evidence of safety and effectiveness for a specific use and manufacturing process.	Prescription GLP-1 medicines approved for chronic weight management
Compounded	A pharmacy prepares a customized version of a drug, usually under specific legal conditions. It is not the same as an approved product.	Some pharmacy-prepared versions of drugs in shortage or with a clinical need
Investigational or "research use"	Studied in labs or trials, not approved for any human use.	5-Amino-1MQ

Two more cautions. First, a facility being registered with the FDA does not mean the products it makes are approved. Registration is a listing, not a review of a product. Second, labels such as "research compound," "not for human consumption" or "supplement" are legal positioning by sellers. They are not a quality signal, and they do not tell you what is in the container.

We have not been able to confirm that any form of 5-Amino-1MQ meets the requirements of an approved human drug. If a seller says otherwise, ask for the FDA documentation and look it up yourself.

Reading an online product page

The pages that rank for this topic often show certificates of analysis, purity percentages such as 99%, "third-party tested" badges and star ratings. Here is how to read them.

Purity is not safety. A high-performance liquid chromatography (HPLC) result says how much of one substance is in a sample. It says nothing about whether that substance helps or harms a person.
A certificate is only as good as its link to your product. Check that the lot number on the certificate matches the lot on your container, and who ran the test.
Reviews are not trials. Customer ratings reflect expectations, placebo response and selection. Weight changes in the first weeks of any diet change are common.
Doses on sales pages are borrowed. They are typically scaled from animal studies or copied from other sellers.

If a page promises fat loss without losing muscle, fewer side effects than prescription options, or results by a certain date, treat those as marketing claims, not findings. Nothing we reviewed supports them in humans.

Possible risks to take seriously

Because there are no human trials, the full list of risks is unknown. That is itself a risk. Specific concerns a clinician would raise:

Unknown dose-response. Too little may do nothing, and too much may cause effects nobody has measured.
Product quality. Gray-market products vary in identity, strength and contamination, and injectable forms add infection risk.
Drug interactions. Enzymes like NNMT take part in methylation and liver processing. How a blocker interacts with your medicines is unstudied.
Delayed care. Spending months on an unproven product can postpone a workup for thyroid disease, insulin resistance, sleep apnea, low testosterone or menopause-related changes, all of which can affect weight and energy.

See a clinician before using it, and sooner if you are pregnant or trying to conceive, have kidney or liver disease, take prescription medicines, or have a history of cancer or eating disorders. If you have already taken it and develop chest pain, trouble breathing, fainting, severe abdominal pain or jaundice, seek urgent care and bring the product container with you.

What has human evidence for weight management

If your goal is to lose weight or improve metabolic health, options with human trial data exist, and a licensed clinician decides who qualifies. Start with these background reads:

GLP-1 for weight loss: what the evidence actually shows gives the overview.
Semaglutide for weight loss and tirzepatide for weight loss cover the two best-studied drugs, including who they are and are not for.
Peptide therapy benefits: what's proven and what isn't sorts the broader peptide category.
If you are curious about mitochondria and metabolism, what MOTS-c research shows so far is another example of strong mouse data and limited human data.

These medicines are not risk-free. Nausea, constipation and other digestive effects are common, and a gastroenterologist's clinic-ready steps for managing GI side effects on GLP-1 therapy are useful to read before starting, so you know what to report and when.

Our perspective

We see the same pattern again and again: a compound with an exciting mouse result becomes a trending supplement before anyone has studied it in people. The mouse paper is real science. The gap between it and a capsule marketed to adults is where readers get hurt.

Mouse research, supplement marketing, missing human studies

Our approach is simple. We publish education that separates approved, compounded and investigational products, we say when evidence is missing, and we leave treatment decisions to a qualified clinician. We do not provide doses or injection instructions for investigational compounds, and we do not suggest that any consultation will result in a prescription. What a clinician recommends depends on your history, exam and labs.

If you take one thing from this page, let it be this: the right question is not "how do I take 5-Amino-1MQ?" It is "what is driving my weight or energy, and which options have human evidence for someone like me?"

— AirMedFit

How to prepare for a clinician conversation

If you want to raise this compound or any metabolic supplement with a clinician, bring:

A full list of what you take, including supplements, peptides and anything bought online, with product names and lot numbers if you have them.
Your weight history, including diets tried and how your weight changed over time.
Recent labs, if you have them. Useful baselines include glucose or HbA1c, lipids, liver and kidney function and thyroid tests. Our guide to a metabolic panel for weight loss explains what each one tells you.
Symptoms and timing, such as fatigue, sleep changes, hot flashes, low libido or mood changes, since hormone shifts can mimic or drive weight problems. Our look at HRT and weight loss discusses that link.
Specific questions: Is this product approved for any use? What is the evidence in humans? What could it interact with? What would you check first?

A good clinician will tell you plainly when the answer is "there is no evidence yet."

Talking to a clinician through AirMedFit

AirMedFit's site lists doctor consultations and lab panels for adults who want to discuss hormones, weight and metabolic health. The consultation page has the current details, and the consultation listings show two formats: an Async Doctor's Consult at 49 USD one-off and a Sync Doctor's Consult at 120 USD one-off, as published when we last checked. The medical services collection lists home-kit lab panels, including Men's Essential at 129 USD and Women's Essential at 139 USD, both one-off.

Confirm current availability, what a visit covers and what follow-up looks like on those pages before you book. A consultation is a conversation with a clinician, and it does not guarantee a prescription or a particular treatment. You can also start from the AirMedFit home page.

FAQ

What does 5-Amino-1MQ do?

In obese mice, it reduced body weight, fat tissue and cholesterol in published experiments. In humans, we do not know what it does, because we found no registered human trials. Anything beyond the mouse findings is speculation.

Is 5-Amino-1MQ a peptide?

No. It is a small-molecule NNMT inhibitor, a different chemical class from peptides. It is often sold next to peptides, which causes the mix-up.

How long does it take to work, and how often should it be taken?

No human data answer either question, so we do not give a schedule. Dosing found online is extrapolated from animals or copied between sellers. A clinician can discuss options with proven dosing instead.

Can you take it with NAD+ or GLP-1 medicines?

There are no human studies of those combinations that we could find, so safety and benefit are unknown. If you already take a prescription GLP-1 or an NAD+ product, tell your prescriber before adding anything else.

Is it legal to buy?

Sellers often label it for "research use," which does not make it an approved medicine for people. Ask your clinician or pharmacist about the legal and safety status of any specific product before use.